Inventiva IVEVF
NASDAQ IVEVF
$3.59 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Inventiva (IVEVF) Other Non-Current Liabilities (2023 - 2025)

Inventiva (IVEVF) posted Other Non-Current Liabilities of $1.4 million for Q4 2025, up 8.95% on a QoQ basis from $1.3 million in Q2 2025, and up 25.93% year-over-year from $1.1 million in Q4 2024.

Analysis

Inventiva (IVEVF) Other Non-Current Liabilities (2023 - 2025) Analysis & Trends

Inventiva has reported Other Non-Current Liabilities for 3 years, with the latest figure at $1.4 million in Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 25.93% year-over-year to $1.4 million in Q4 2025; TTM through Dec 2025 was $1.4 million, a 25.93% increase from a year earlier, with the FY2025 full-year figure at $1.4 million, up 25.93% from the prior year.
  • Other Non-Current Liabilities was $1.4 million for Q4 2025 at Inventiva, up from $1.3 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $1.4 million in Q4 2025, with the low at $1.1 million in Q4 2024.
  • Average Other Non-Current Liabilities over 3 years is $1.2 million, with a median of $1.1 million recorded in 2024.
  • The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities fell 0.68% in 2024, then increased 25.93% in 2025.
  • Over 3 years, Other Non-Current Liabilities stood at $1.1 million in 2023, then decreased by 0.68% to $1.1 million in 2024, then grew by 25.93% to $1.4 million in 2025.
  • The last three Other Non-Current Liabilities figures came in at $1.4 million (Q4 2025), $1.3 million (Q2 2025), and $1.1 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.23 Bn 44.23 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn
10 Inventiva 693.72 Mn 693.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.39 Mn
Jun 30, 2025 1.27 Mn
Dec 31, 2024 1.10 Mn
Jun 30, 2024 1.11 Mn
Dec 31, 2023 1.11 Mn